Skip to main content
. 2020 Feb;40(1):26–32. doi: 10.14639/0392-100X-N0326

Table I.

Patient and disease characteristics.

Number of patients (%)
Total number of patients 540
Gender
M 358(66)
F 182(34)
Age (at the time of multidisciplinary discussion)
Mean (range) year 61.8 (20-90)
Median (IQR) year 63.0 (52.9-71.6)
Head and Neck sites
Oral cavity 98(18)
Oropharynx 152(28)
Hypopharynx 24(4)
Larynx 100(19)
Salivary glands 60(11)
Skin 17(3)
Nasal cavity and paranasal sinuses 16(3)
Lymph node metastasis from unknown primary 12(2)
Recurrences of nasopharyngeal tumours 5(1)
Other head and neck sites 56(11)
Histology
Squamous cell carcinoma 391(72)
Adenocarcinoma 15(3)
Adenoid cystic carcinoma 23(4)
Pleomorphic adenoma 17(3)
Mucoepidermoid tumours 6(1)
Sarcoma 9(2)
Schwannoma 2 (0.5)
Paraganglioma 2 (0.5)
Neuroendocrine tumours 3 (0.6)
Benign histology 9(2)
Other histology 17(3)
N.A. at the time of discussion 46(9)

CUP: cancer of the unknown primary; HNC: head and neck cancer; IQR: interquartile range; N.A.: not available; SCC: squamous cell carcinoma.